Verrica Pharmaceuticals Inc.VRCANASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$3.25
Net Income/Share$-2.74
Operating CF/Share$-3.07
Free CF/Share$-3.07
Cash/Share$2.22
Book Value/Share$-1.80
Tangible Book/Share$-1.80
Equity/Share$-1.80
Interest Debt/Share$4.69
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$70.70M
Enterprise Value$85.34M
P/E Ratio-2.72P/S Ratio2.29P/OCF Ratio-2.43
P/FCF Ratio-2.43
P/B Ratio-4.15P/TB Ratio-4.15
EV/Sales2.77EV/EBITDA-5.21
Graham Valuation
Graham Number--
Graham Net-Net$-3.18
Profitability
Earnings Yield-36.79%FCF Yield-41.16%ROE165.27%ROIC-65.23%Return on Tangible Assets-63.61%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue10.99%
SG&A/Revenue47.78%
R&D/Revenue24.33%
Liquidity & Solvency
Debt/Equity-2.10Debt/Assets0.87Debt/Market Cap0.51
Net Debt/EBITDA-0.89
Current Ratio1.25Interest Coverage-1.87xIncome Quality1.12Efficiency
Days Sales Outstanding87 days
Days Payables Outstanding232 days
Days Inventory337 days
Receivables Turnover4.21x
Payables Turnover1.58x
Inventory Turnover1.08x
Capital Structure
Tangible Assets-$17.04M
Working Capital$7.37M
Invested Capital$9.26M
Intangibles/Assets0.00%